Results 171 to 180 of about 12,579 (242)

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Reduction of Simian-Human Immunodeficiency Virus 89.6P Viremia in Rhesus Monkeys by Recombinant Modified Vaccinia Virus Ankara Vaccination

, 2001
Dan H. Barouch, Sampa Santra, Marcelo J. Kuroda, Jörn E. Schmitz, Ronald J. Plishka, Alicia Buckler‐White, Alicia Gaitan, Rebekah Zin, Jae‐Hwan Nam, Linda S. Wyatt, Michelle A. Lifton, Christine E. Nickerson, Bernard Moss, David C. Montefiori, Vanessa M. Hirsch, Norman L. Letvin   +15 more
openalex   +1 more source

Robust polyfunctional CD8⁺ and CD4⁺ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein. [PDF]

J Gen Virol
Tscherne A, Kalodimou G, Jany S, Freudenstein A, Kumar S, Pilchová V, Friebis T, Maiwald G, Panhofer I, Sutter G, Volz A.   +10 more
europepmc   +1 more source

Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells. [PDF]

Proc Natl Acad Sci U S A, 2020
Peng C, Moss B.
europepmc   +1 more source

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. [PDF]

Lancet Infect Dis, 2020
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM.   +24 more
europepmc   +1 more source

Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice. [PDF]

J Virol
Zhu J, Wang Z, Li Y, Zhang Z, Ren S, Wang J, Xie S, Liao Z, Song B, Wu W, Yan F, Peng C.   +11 more
europepmc   +1 more source

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages. [PDF]

Front Immunol
Neckermann P, Mohr M, Billmeier M, Karlas A, Boilesen DR, Thirion C, Holst PJ, Jordan I, Sandig V, Asbach B, Wagner R.   +10 more
europepmc   +1 more source

Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. [PDF]

Vaccines (Basel)
Kubinski M, Beicht J, Gerlach T, Aregay A, Osterhaus ADME, Tscherne A, Sutter G, Prajeeth CK, Rimmelzwaan GF.   +8 more
europepmc   +1 more source

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

, 2002
Rama Rao Amara, François Villinger, Silvija I. Staprans, John D. Altman, David C. Montefiori, Natalia Kozyr, Yan Xu, Linda S. Wyatt, Patricia L. Earl, James G. Herndon, Harold M. McClure, Bernard Moss, Harriet L. Robinson   +12 more
openalex   +1 more source

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus. [PDF]

Front Immunol
Diaz-Cánova D, Moens U, Brinkmann A, Nitsche A, Okeke MI.   +4 more
europepmc   +1 more source